Active Shortage

APO-OLMESARTAN/HCTZ

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-OLMESARTAN/HCTZ in Canada?

Yes. APO-OLMESARTAN/HCTZ 12.5MG 20MG has an active shortage reported to Health Canada (last updated September 16, 2024).

Why is APO-OLMESARTAN/HCTZ not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-OLMESARTAN/HCTZ be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist

StatusActive Shortage

Same-ingredient products on fileNone found

Affected strength12.5MG 20MG

Last updated2024-09-16

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

DIN

02453606

Strength

12.5MG 20MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL

Tier

Unrated

Last Updated

2024-09-16

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244